Fierce Pharma

JULY 19, 2023

After Novo Nordisk's popular obesity medicine Wegovy went into short supply, people turned to the company first-generation weight-loss drug, Saxenda, for treatment. | After Novo Nordisk's Wegovy became hard to come by, people turned to the company first-generation weight loss drug, Saxenda, for treatment. Now, the company is struggling to handle demand for that product.

Medicine 240

Medicine 240

Pharma Marketing Network

JULY 19, 2023

Sponsorships can be a powerful tool for pharmaceutical companies to engage with communities and make a positive impact on health and wellness. When done right, sponsorships can help pharmaceutical companies connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. Here are some examples of how pharmaceutical companies can use sponsorships to engage communities: Sponsoring community health events: Pharmaceutical companies can s

Pharmaceutical 98

Pharmaceutical Healthcare Healthcare Education 98

Fierce Pharma

JULY 19, 2023

While vaccines for COVID-19 have certainly enjoyed the spotlight in recent years, rates of uptake for other shots have sharply declined. | The GSK-funded report looked at adult vaccination data and found a major slump in vaccine adoption over the last few years, save for COVID vaccines.

207

207

Pharma Marketing Network

JULY 19, 2023

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry Content marketing is a long-term strategy that can help businesses of all sizes generate leads, increase brand awareness, and drive sales. By creating and distributing valuable content, businesses can attract and engage their target audience, position themselves as experts in their field, and build trust with potential customers.

Marketing 98

Marketing Pharmaceutical Sales Education 98

Advertisement

Distribution

Fierce Pharma

JULY 19, 2023

Right on the heels of a major study win for its star drug Vyvgart, argenx has raised more than $1 billion in cash to support its operations. | Right on the heels of a major study win for its star drug Vyvgart, argenx has raised more than $1 billion in cash to support its operations.

206

206

Pharma Marketing Network

JULY 19, 2023

Sponsorships can be a powerful way for businesses to connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. But in order to be truly effective, sponsorships must be aligned with a company’s brand values. For pharmaceutical companies, this means aligning sponsorships with causes that are related to health and wellness.

Pharmaceutical 98

Pharmaceutical Healthcare Healthcare Education 98

Copyright Clearance Center

JULY 19, 2023

Together, this panel reflected on successful collaborations that streamline OA processes, remove unnecessary work for the researchers, and enable cross-stakeholder transparency.

96

96

Fierce Pharma

JULY 19, 2023

Amarin has hired a new CEO, Patrick Holt, and will lay off nearly a third of its employees, including its entire sales force in the United States.

Sales 181

Sales 181

Pharma Marketing Network

JULY 19, 2023

Sponsorships can be a powerful tool for pharmaceutical companies to engage with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. But with so many different healthcare organizations and causes to choose from, it can be difficult to know where to start. Here are some tips for choosing the right sponsorships for maximum impact in the pharmaceutical industry: Start with your goals: What do you hope to achieve through your sponsorship?

Pharmaceutical 97

Pharmaceutical Education Healthcare Healthcare 97

European Pharmaceutical Review

JULY 19, 2023

Phase II study results for navacaprant (NMRA-140), a novel kappa opioid receptor (KOR) antagonist for major depressive disorder (MDD) demonstrated significant and clinically meaningful improvement in depression for participants. The data “are compelling, particularly the significant improvements observed in both depressive and anhedonic symptoms,” stated Dr Roger S McIntyre, FRCPC, Professor of psychiatry and pharmacology, University of Toronto and Executive Director of the Brain and Cogni

Pharmacology 94

Pharmacology Patients Safety Medicine 94

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

Pharma Marketing Network

JULY 19, 2023

The pharmaceutical industry is constantly evolving, and digital technology is playing an increasingly important role in marketing campaigns. In the past, pharmaceutical companies relied heavily on traditional marketing methods such as print ads, TV commercials, and direct mail. However, these methods are becoming less effective as consumers are increasingly turning to digital channels for information and research.

Marketing 96

Marketing Pharma Media Healthcare Provider 96

MedCity News

JULY 19, 2023

Peppermint is an “online clubhouse community” for adults aged 55 and older that allows them to connect with others through online clubs (like for traveling or gardening), workshops (like for nutrition or photography) and collaboration (where members can work together on activities like creating a recipe book). It aims to reduce loneliness by creating a sense of community and purpose for older adults, Peppermint’s CEO said.

92

92

European Pharmaceutical Review

JULY 19, 2023

The European Commission, the Heads of Medicines Agencies (HMA) and the European Medicines Agency have published recommendations for avoiding antibiotic shortages in the autumn/winter 2023-2024 season. These suggested actions have been developed through the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG). They complement the process to develop an EU list of critical medicines, of which a first version is anticipated to be released by the end of 2023.

Medicine 83

Medicine Manufacturing Safety Pharmaceutical 83

MedCity News

JULY 19, 2023

The restructuring of cardiovascular drugmaker Amarin means the layoff of about 30% of staff. Sales of Vascepa, the company’s only commercialized product, have suffered as generic versions gain traction in the market.

Competition 83

Competition Sales Marketing Biopharma 83

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

PharmaVoice

JULY 19, 2023

Stevanato’s focus on biologic-related vials and delivery devices has put it in a unique position amid a quickly growing market.

Manufacturing 96

Manufacturing Marketing 96

Pharmaceutical Technology

JULY 19, 2023

Twist Bioscience and CRUK innovation arm Cancer Research Horizons have signed an agreement for licensing a library of libraries.

98

98

Medgadget

JULY 19, 2023

Nevro , a medtech company based in California, has developed the HFX iQ spinal cord stimulation system, which is intended to treat chronic pain. While spinal cord stimulators can be very useful in controlling certain types of chronic pain, at present, patients must attend with their clinician to obtain adjustments to their stimulator. This is inconvenient for both patient and clinician alike.

Patients 72

Patients Healthcare Healthcare Doctors 72

Pharmaceutical Technology

JULY 19, 2023

B. pseudomallei is resistant to many antibiotics and, without treatment, can be lethal to those infected.

98

98

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

PharmaTimes

JULY 19, 2023

Illumina and Nashville Biosciences’ have announced AbbVie, Amgen, AstraZeneca, Bayer and Merck as founding members - News - PharmaTimes

78

78

Medgadget

JULY 19, 2023

Researchers at UCLA have developed a wearable patch that can measure muscle movements in underlying tissues. The patch contains nanomagnets, and movements in underlying muscles can deform the resulting magnetic fields, creating an electric current. This both provides a readable signal for the system, and also means that the system is self-powered and does not require a battery.

Electronics 69

Electronics Leads Patients Medicine 69

MedCity News

JULY 19, 2023

Medicaid managed care organizations deny prior authorization requests at high rates, according to a recent report by the Office of Inspector General. Of the 115 MCOs the OIG analyzed, 12 had prior authorization denial rates above 25%.

Management 74

Management 74

Medgadget

JULY 19, 2023

Researchers at Florida Atlantic University have developed a soft robotic glove that can assist stroke patients to relearn how to perform dexterous tasks with their hands. The glove contains soft actuators that helps patients to move their fingers as they perform tasks, and sensors that help to create tactile sensations. So far, the researchers have focused on using the gloves to assist patients to play music.

Patients 68

Patients Training 68

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

PharmaTimes

JULY 19, 2023

By combining both netarsudil and latanoprost treatment, Roclanda reduces intraocular pressure - News - PharmaTimes

76

76

Medgadget

JULY 19, 2023

Scientists at Penn State have developed an assay that lets them to directly measure HIV viral load in a drop of blood. The technology is also faster and less expensive than current approaches. At present, RT-PCR is typically used to assess HIV levels in a patient’s blood, requiring genetic material to be amplified before it can be measured. This is time-consuming and does not provide a direct measurement of viral loads, but rather a close estimate.

Patients 57

Patients Medicine 57

PharmExec

JULY 19, 2023

Artificial intelligence may find a home in clinical trials and manufacturing in the coming years, but privacy, cyber security, and determining who owns the intellectual properties could pose challenges.

Manufacturing 52

Manufacturing 52

PM360

JULY 19, 2023

The Point of Care Marketing Association (POCMA), a nonprofit organization to support the continued growth of the Point of Care (POC) channel through education and advocacy, recently welcomed two new members, CMI Media Group WPP’s healthcare specialist media planning agency, and Compas , a NMSDC-certified diverse-owned media buying agency. “This is an exciting time for POCMA and we are thrilled to welcome partner agencies CMI Media Group and Compas as agency members,” said POCMA President, Nicole

Media 52

Media Marketing Education Physicians 52

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

Legacy MEDSearch

JULY 19, 2023

Francis Medical, Inc., a privately held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of prostate, kidney, and bladder cancer, today announced the first patient has been treated in the company’s VAPOR 2 pivotal clinical study evaluating the safety and efficacy of its Vanquish minimally invasive water vapor ablation therapy for managing prostate cancer.

Medical 52

Medical Side effects Patients Recruitment 52

Pharma Marketing Network

JULY 19, 2023

Cookieless Tracking in the Pharmaceutical Industry Cookies are small text files that are stored on a user’s computer when they visit a website. These cookies can be used to track the user’s browsing activity across different websites, which allows advertisers to target them with relevant ads. However, cookies are becoming increasingly unpopular, as users are becoming more aware of their privacy implications.

Pharmaceutical 52

Pharmaceutical Patients Medical Networking 52

Clarivate

JULY 19, 2023

To turn a patent portfolio into a strategic asset, you need to see both the forest and the trees. Within this blog, we explore the process and value of optimizing your patent strategy through a three-phase patent portfolio analysis. Patents are more than legal instruments. They are powerful business assets and keys to commercial success. This point of view is widespread among corporate executives and legal departments.

Competition 52

Competition Management Marketing 52

Pharmaceutical Technology

JULY 19, 2023

Amarin Corporation has initiated a company restructuring programme, following a business review by its new board and senior management team.

Management 52

Management 52

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management